Breast imaging software developer Volpara Solutions is highlighting the European launch of two new additions to its line of automated breast density assessment and enterprise analytics software, along with new research, at ECR 2016 in Vienna.
The new software helps radiologists address the requirement in the BI-RADS 5th Edition Atlas to provide "an overall assessment of the volume of attenuating tissues in the breast, to help indicate the relative possibility that a lesion could be obscured." Volpara Density Map has been cleared by the U.S. Food and Drug Administration (FDA). It presents 3D quantitative volumetric information created by the VolparaDensity algorithm in a 2D image that is available as an additional DICOM secondary capture image, the firm said.
The other addition, VolparaEnterprise, is a work-in-progress that provides real-time quality assurance and performance monitoring through interactive dashboards. It's designed to help facilitate the evaluation of mammography and tomosynthesis system utilization, examination times, patient dose, patient positioning, and patient comfort.
Volpara is also showcasing updates available with VolparaDensity v3.1, its density assessment tool available clinically for use with digital breast tomosynthesis datasets from Hologic, GE Healthcare, and Siemens tomosynthesis systems. Updates include configurable patient scorecards, a high-capacity server, and the ability to route patient results by Volpara's Volpara Density Grades, which are correlated to the BI-RADS density categories.
Finally, Volpara is highlighting eight abstracts to be presented at ECR 2016. The six posters and two scientific session presentations explore the use of Volpara's automated breast density and quantitative breast imaging software tools to provide breast density results correlated to the 4th and 5th Editions of the BI-RADS Atlas, to monitor temporal changes in breast density, and improve mammographic compression and positioning, according to Volpara.
